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A concept fundamental to viral pathogenesis is that infection induces specific changes within the host cell, within
specific tissues, or within the entire animal. These changes are reflected in a cascade of altered transcription patterns
evident during infection. However, elucidation of this cascade in vivo has been limited by a general inability to
distinguish changes occurring in the minority of infected cells from those in surrounding uninfected cells. To
circumvent this inherent limitation of traditional gene expression profiling methods, an innovative mRNP-tagging
technique was implemented to isolate host mRNA specifically from infected cells in vitro as well as in vivo following
Venezuelan equine encephalitis virus (VEE) infection. This technique facilitated a direct characterization of the host
defense response specifically within the first cells infected with VEE, while simultaneous total RNA analysis assessed
the collective response of both the infected and uninfected cells. The result was a unique, multifaceted profile of the
early response to VEE infection in primary dendritic cells, as well as in the draining lymph node, the initially targeted
tissue in the mouse model. A dynamic environment of complex interactions was revealed, and suggested a two-step
innate response in which activation of a subset of host genes in infected cells subsequently leads to activation of the
surrounding uninfected cells. Our findings suggest that the application of viral mRNP-tagging systems, as introduced
here, will facilitate a much more detailed understanding of the highly coordinated host response to infectious agents.
Citation: Konopka JL, Penalva LO, Thompson JM, White LJ, Beard CW, et al. (2007) A two-phase innate host response to alphavirus infection identified by mRNP-tagging in
vivo. PLoS Pathog 3(12): e199. doi:10.1371/journal.ppat.0030199
Introduction
At the interface of pathogen infection and host response
lies a complex network of regulated interactions. As the host
seeks to eradicate the pathogen and maintain survival, the
pathogen itself seeks to continue its own proliferation at
whatever cost is necessary to the host cell.
Therefore, the insult associated with viral infection often
involves numerous changes in host gene expression. Funda-
mental to many viral pathogenesis studies is the investigation
of these specific changes within the host cell, or on a more
global scale, within a specific tissue, organ, or the entire
animal. Although it has been possible in several systems to
singularly identify cellular genes that are altered in expres-
sion due to infection, these genes most likely represent a very
small fraction of all the genes induced or repressed. In an
attempt to more fully understand the interactions between
pathogen and host, virologists have turned to high-through-
put genomic profiling technologies within the past decade to
evaluate the status of host gene expression post-infection.
Although widely informative, there remains an inherent
limitation in applying these analyses to viral pathogenesis
studies. In the absence of an acutely susceptible system in
which all cells can be uniformly infected, a heterogeneous
environment of infected and uninfected cells naturally exists
during viral infection. This is particularly true in vivo, where
only a minority of cells in a given tissue or organ are infected,
even when that tissue is a major target of infection. In
traditional gene expression analysis utilizing total RNA
isolation, there is an inability to discriminate the population
of host mRNAs isolated from the infected cells versus the
surrounding uninfected cells. As the percentage of unin-
fected cells is high in vivo, mRNA from uninfected cells likely
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creates background signal that skews or masks the analysis
from infected cells. Discriminating the direct viral impact on
infected cells from the subsequent effects on bystander
uninfected cells is critical to fully understanding the patho-
genesis of a given virus, yet most analyses lack this distinction.
To circumvent this limitation, we have optimized and
implemented an innovative mRNP-tagging technique to
isolate host mRNA specifically from infected cells following
viral infection in cultured cells as well as tissues in vivo. The
mRNP-tagging technology was originally developed from a
functional genomics approach termed ribonomics, which
examines mRNAs functionally clustered in ribonucleoprotein
complexes [1,2]. The mRNP-tagging system takes advantage of
the natural interaction of RNA-binding proteins with cellular
mRNA to effectively enrich and isolate messages from a
specific minority cell type within a heterogeneous environ-
ment. One such interaction that has been used in several
systems is the well established strong binding of poly(A)
binding protein I (PABP) to the poly(A) tail of cellular
mRNAs prior to translation [3–8]. In the mRNP-tagging
technique, a unique version of PABP engineered with an
epitope tag is expressed in a cell- or tissue-specific manner.
The cellular mRNA bound to the tagged-PABP is then co-
immunoprecipitated using an anti-epitope antibody, enrich-
ing the mRNA from the targeted cell population and
separating it from the mRNA of the surrounding cells or
tissues [1,2,9]. Gene profiling methods such as cDNA micro-
arrays or quantitative real-time PCR can then be performed
using the enriched mRNA population to assess the gene
expression status within the cell or tissue population of
interest. This method has been successfully applied to
identify tissue-specific mRNA populations in Caenohabditis
elegans and Drosophila melanogaster [10–13], as well as to identify
cell type-specific gene expression changes in mixed cell
culture models in vitro [14].
Here, we have adapted the mRNP-tagging technique to
characterize host gene expression changes following infection
with Venezuelan equine encephalitis virus (VEE). VEE is an
arthropod-borne, single-stranded (þ)sense RNA virus associ-
ated with periodic epidemics and equine epizootics in the
Western Hemisphere, and serves as a leading model for the
study of alphavirus pathogenesis [15]. Numerous studies have
underscored the dramatic role of virus genetics and the
subsequent host defense response in dictating the course and
outcome of VEE infection [16–32]. Although infection in the
murine model has been well studied for some time, little is
known concerning the molecular markers of VEE-induced
disease, including the direct effects on host cell gene
expression. VEE infection is characterized by two distinct
disease phases following infection in humans, horses, and
mice: An initial lymphotropic phase characterized by a high
serum viremia, followed by invasion of the central nervous
system and initiation of a neurotropic phase leading to
encephalitis. In horses and mice, progression to the neuro-
tropic phase occurs at very high frequency. Previous studies in
our laboratory have carefully examined the progression of
pathogenesis in the mouse model, utilizing molecularly cloned
infectious VEE as well as an extensive panel of mutants
blocked at various stages of infection [18,21,22,25,27,29]. The
draining lymph node (DLN), and in particular the dendritic
cells, was subsequently identified as the initial site of viral
replication, with infected Langerhans cells migrating there
from the site of inoculation in the footpad [20]. It has been
hypothesized that the early events within the DLN set the stage
for the VEE-specific pattern of virus replication and host
response. However, many details of the earliest stages of VEE
infection remain largely undefined, with the innate host
response likely playing a major role.
To define the molecular profile of the early virus–host
interactions central to VEE pathogenesis, we took advantage
of several tools. One tool paramount to studying the early
events in infection are VEE replicon particles (VRP). VRP are
propagation-defective vector particles that undergo only one
round of infection, as the structural genes which normally
drive the assembly of progeny virions are deleted and
replaced with a marker gene of interest [33]. As such, VRP
replication is limited to the first infected cells, allowing us to
model the earliest events of VEE infection. In addition, the
application of an mRNP-tagging technology offers an
opportunity for a distinct view of the VEE-induced changes
in host gene expression. By expressing an epitope-tagged
version of PABP from VRP, host messages induced specifi-
cally within the first round of infected cells can be
fractionated from those of the surrounding uninfected cells.
Through co-immunoprecipitation with antibody to the
epitope tag, the infected cell host mRNA bound to the
VRP-delivered tagged-PABP can be isolated and screened as a
discrete mRNA population for changes in host gene
expression. This technology enables discrimination of unin-
fected cells from infected cells, and specifically profiles the
changes induced in the infected cell population—a distinc-
tion that previously has been difficult to achieve, particularly
in vivo where the infected cells may be only a small minority
in a given tissue (e.g., in the DLN post-VRP infection).
Using VRP to infect primary dendritic cells in vitro, and to
limit infection to the initially infected cells in vivo, we have
elucidated gene expression patterns that define the early
stages of VEE pathogenesis, including members of the
interferon (IFN) and proinflammatory host defense pathways.
This analysis revealed multifactorial interactions that occur
within the virus-infected host, and indicated a two-phase
innate response characterized by cytokine and antiviral gene
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Author Summary
A major element of viral pathogenesis is the induction of specific
changes within the infected host, often reflected in altered gene
expression patterns. However, revealing these changes in vivo has
been limited by an inability to distinguish changes within the
minority of infected cells from that in surrounding uninfected cells.
Here we introduce a viral mRNP-tagging system, based on
Venezuelan equine encephalitis virus (VEE), that enables the
isolation of host mRNA specifically from infected cells in vitro and
in vivo, even when they are a small minority. This system allowed us
for the first time to monitor the innate response specifically within
the cells initially infected in vivo. In combination with simultaneous
analysis of the entire tissue response, the result was a multifaceted
view of the innate response to VEE in dendritic cells, and in the
draining lymph node. The results supported a two-step response in
which activation of host genes within infected cells leads to
activation of bystander cells, offering insight into the process by
which the greater innate immune response to alphaviruses is
established in vivo. This system may be employed for a wide variety
of pathogens, offering broader implications to the manner in which
interactions between pathogens and their hosts are studied.
induction profiles in the first infected cells that were distinct
from that of uninfected bystander cells within the same
tissue. By elucidating these specific and distinct host
responses, systems such as the VRP mRNP-tagging approach
have the potential to further our understanding of the
complex interactions between pathogens and their hosts.
Results
Establishment of the VRP mRNP-Tagging System
An mRNP-tagging technique has been optimized and
applied to isolate mRNA specifically from the infected cell
population following VRP infection. The fundamental basis
of mRNP-tagging relies on the natural interaction of RNA-
binding proteins with RNA, with the synthesis of a uniquely
tagged RNA binding protein in target cells enabling the
isolation of the specific mRNA population through tag-
specific antibodies and co-immunoprecipitation. To apply
this technique to a virus infection model, a FLAG epitope-
tagged version of PABP was delivered specifically to infected
cells by engineering the virus itself to express the unique
RNA-binding protein. The PABP coding sequence, with the
FLAG epitope fused in frame at the 59 end, was cloned
directly downstream of the 26S promoter of the VEE replicon
plasmid (Figure 1A), and the replicon RNA was packaged into
VEE replicon particles to generate FLAG-PABP VRP. Upon
infection of BHK and L929 cells, the FLAG-PABP VRP
programmed the robust expression of the epitope-tagged
version of PABP, as determined by anti-FLAG immunopre-
cipitation as well as by western blotting and from cell lysates
(Figure 1A). Robust levels of expression were expected based
on the documented high level of transgene expression from
the 26S mRNA promoter of VRP [33], a key element for this
VRP mRNP-tagging system.
An outline of the VRP mRNP-tagging procedure is shown
in Figure 2. Briefly, following infection with FLAG-PABP VRP
at low multiplicity of infection (MOI), the FLAG-tagged PABP
molecule is synthesized only in the infected cells as the
replicon RNA is expressed. At various times post-infection
the cells are lysed, releasing PABP-bound messages. Pre-
cleared lysate is mixed with agarose beads coated with anti-
FLAG antibody. The mRNA from the infected cells is
immunoprecipitated specifically via the FLAG epitope of
the PABP bound to the message in the RNP complex, as this
form of PABP is only present in VRP-infected cells. The
message is subsequently isolated from that complex by
proteinase K digestion and phenol-chloroform based extrac-
tion. RNase protection assays (RPAs) were initially utilized to
detect host messages following the anti-FLAG immunopreci-
pitation from infected L929 cell extracts, and verified that the
VRP-supplied tagged-PABP was in fact bound to host
messages, and the host mRNA could be isolated and used in
gene expression assays. Bead saturation studies were com-
pleted to determine the concentration of immunoprecipitat-
ing antibodies that would ensure antibody excess in
immunoprecipitating the PABP-bound mRNA population
(data not shown).
An issue that could complicate the precise nature of the
profiling involved in mRNP-tagging systems is the potential
for promiscuous exchange or reassortment of endogenous
and tagged-PABP among mRNAs in cell extracts. To alleviate
concern in this matter, several groups have employed the use
of formaldehyde crosslinking to increase the stability of the
mRNA-PABP interaction during immunoprecipitation [10–
13]. However, in studies where this treatment was assessed, it
was found that crosslinking had little to no effect on the level
of mRNA enrichment from the target populations [9,13].
Additionally, the degree of crosslinking that is effective,
without irreversibly linking the mRNA to the protein and
thus dampening RNA recovery, may be difficult to determine.
Published studies demonstrating that mRNA originally bound
to PABP in cell lysates can not be displaced by competing
excess poly(A) RNA or free PABP also alleviated concerns of
PABP reassortment [9].
Nonetheless, we designed an experiment to address the
degree, if any, of PABP reassortment in our system. L929 cells
were pretreated with actinomycin D (AMD) for 1 h prior to
infection with FLAG-PABP VRP, with infection proceeding
under continued AMD treatment. AMD inhibits DNA-
dependent RNA transcription, thereby preventing the syn-
thesis of new host RNA during infection. Importantly, the
treatment of cells with AMD at or shortly before alphavirus
infection does not inhibit viral RNA-dependent RNA syn-
thesis [34]. Therefore, when AMD pretreated cells were
subsequently infected with FLAG-PABP VRP, the FLAG-
tagged PABP was expressed from the VRP, however no new
Figure 1. VEE Replicon Constructs
The VEE replicon genome encodes the viral nonstructural genes, the
authentic 59 and 39 UTR, as well as a cloning cassette downstream of the
26S subgenomic promoter for transgene insertion. Schematic represen-
tation of the replicon constructs used in this study are shown.
(A) FLAG-PABP VRP, expressing an N-terminally FLAG-tagged version of
PABP (FLAG epitope denoted by checkered shading). Expression of
FLAG-PABP expressed from the VRP, as well as endogenous PABP, is
shown by western blotting against the FLAG epitope or against PABP
itself, from L929 cell lysates harvested at 6 and 12 hpi.
(B) Schematic of GFP-VRP, expressing green fluorescent protein. All
replicon particles used in this study were packaged in the wildtype
(V3000) envelope.
doi:10.1371/journal.ppat.0030199.g001
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host messages were available for binding to the tagged-PABP
delivered by the VRP. The only remaining source of host RNA
available for binding by the VRP-supplied tagged-PABP would
be host mRNA that was present prior to AMD treatment and
infection—the large majority of which would already have
been bound by endogenous PABP. Therefore, unless promis-
cuous exchange or reassortment of endogenous PABP and
tagged-PABP occurred among host mRNAs, there should be
little to no host RNA signal detected upon mRNA-tagging
analysis of AMD-pretreated versus PBS-pretreated cells.
In fact, when the mRNA-tagging technique was used
following FLAG-PABP VRP infection to isolate host mRNA
from AMD-pretreated cells, either a complete absence or
severely reduced levels of host mRNA in anti-FLAG immu-
noprecipitated lysates was observed in comparison to PBS-
pretreated cells (see Figure S1). Therefore, the VRP-supplied
tagged-PABP did not reassort with or out-compete endoge-
nous PABP bound to mRNA during infection. These results,
along with the data generated from other groups, indicated
that PABP reassortment was not a major concern.
Analysis of the Message Population Isolated by VRP
mRNP-Tagging
The fundamental purpose of applying an mRNP-tagging
approach to the examination of the host response during
viral infection is to be able to discern changes in host gene
expression that occur directly within the infected cells. This is
a distinct advantage over traditional profiling techniques,
particularly when infected cells are the minority in the
overall cell population. The mRNP-tagging technique does
isolate a particular subset of mRNA in the cell, namely those
that bind PABP, therefore we wanted to verify that this
method would yield an mRNA population representative of
host transcription following infection. To do so, cells were
infected at a high MOI such that the tagging technique and
the more traditional total RNA isolation would assess profiles
from a similar cell population.
L929 cells, a murine fibroblast cell line, were infected with
FLAG-PABP VRP at an MOI of 5. At 6, 12, or 24 hours post-
infection (hpi), RNA was harvested using each of the
following three methods: 1) For traditional isolation of total
cellular RNA, a commercially available solution of guanidine
salts, urea, phenol and detergent (UltraSpec reagent) was
used. 2) To isolate all poly(A) RNA bound to PABP in the cell
population, an anti-PABP immunoprecipitation assay was
performed on a separate set of mock and VRP-infected cells.
3) Finally, to isolate poly(A) RNA bound to the FLAG-tagged
PABP provided by the FLAG-PABP VRP infection, an anti-
FLAG immunoprecipitation assay was performed. RNA
isolated from all three techniques was used as input RNA in
an RPA designed to analyze the expression profiles of host
genes relevant to this study. The infected cell profile of two
such genes, IRF-1 and IFNb, relative to that in mock infected
cells is shown in Figure 3, with a comparison of the levels as
assayed by the three different RNA isolations. The data shown
are representative of two separate experiments, and the
specific mRNA signal generated from each isolation techni-
que was normalized to GAPDH signal. During a timecourse of
6, 12, and 24 hpi at a high MOI, the message profiles of these
two relevant host genes were similar among the various
methods that were used to isolate RNA. Therefore, the
mRNP-tagging technique was not limiting in terms of the
availability or abundance of RNA screened.
VRP mRNP-Tagging Provides a Sensitive Measure of Viral-
Induced Host Gene Expression
While the RNA populations examined using the VRP
mRNP-tagging system in a high MOI situation lead to
Figure 2. The VRP mRNP-Tagging System
Flowchart illustrating the VRP mRNA-tagging method of isolating mRNA
specifically from infected cells.
(A) Cells are infected with FLAG-PABP VRP, delivering the unique
epitope-tagged version of PABP only to infected cells.
(B) At various times post-infection, cytoplasmic lysates are prepared,
containing the cellular mRNP complexes.
(C) Anti-FLAG antibody–coated agarose beads are added in excess to the
lysate, co-immunoprecipitating the mRNA bound by FLAG-PABP, and
thus fractionating the mRNA in the infected cells from the mRNA in the
surrounding uninfected cells.
(D) The immunoprecipitated mRNA-PABP complex is dissociated using
proteinase K digestion, and the infected cell mRNA is isolated by
standard RNA extraction and precipitation.
doi:10.1371/journal.ppat.0030199.g002
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informative analyses, the truly advantageous use of the
technique is in low MOI situations, where the number of
infected cells are a small minority (i.e., tissues from VRP-
infected animals). Therefore it was important to assess the
level of sensitivity that could be expected in these low MOI
situations. An in vitro experiment was designed to model the
in vivo–like condition of a low frequency infected cell
population. At 6 hpi, cell lysates were prepared from L929
cells that were either mock infected or infected at an MOI of
5 with FLAG-PABP VRP. The cell lysates were mixed in
decreasing ratios of infected cell lysate to uninfected cell
lysate, and the mixed lysate was then immunoprecipitated
with anti-FLAG antibody, isolating the FLAG-PABP bound
mRNA. This mRNA served as template RNA in an RPA, using
probes specific for several host mRNAs. The results (Figure 4)
for two host mRNAs, IRF-1 and GAPDH, demonstrate that the
mRNP-tagging system provides a sensitive measure of VRP-
induced host gene expression, as the signal from FLAG-
tagged host mRNA immunoprecipitated from the infected
cells was detected in samples that contained as little as 1%
infected cell lysate. In this particular experiment, the 1%
value is approximately equal to 2,000 infected cell equiv-
alents. This mRNA signal can be directly visualized in Figure
4, as well as by the raw pixels plotted for IRF-1 in Table S1
and Figure S2. It is worthy to note that RPAs do not include
an amplification step, and as such the input RNA is directly
assayed. Therefore, a higher degree of sensitivity was
expected when shifting to profiling methods that include an
amplification step, such as real-time PCR.
An alternate strategy to assess host gene expression
changes specifically in the infected cell compartment might
rely on the sorting of the infected cell population from the
uninfected cells (e.g., by fluorescence-activated cell sorting
[FACS]), followed by the independent analysis of the RNA
isolated from each population. To further assess the level of
sensitivity, VRP-induced changes in host gene expression as
assessed by the mRNP-tagging method were compared to the
host profile derived by a FACS-based method (Figure 5). L929
cells (2 3 106) were infected at a low MOI of 0.2 with VRP
expressing either GFP (Figure 1B) or FLAG-PABP. At this
MOI, it is estimated that ;10% of L929 cells were infected
(see Figure S3A). At 12 hpi, GFP expression was used as the
basis for FACS-facilitated sorting of the GFP-VRP infected
and uninfected cells into the two respective populations. The
recovered GFP-positive (infected) cells were lysed, and all
PABP-bound host messages were subsequently isolated by
anti-PABP immunoprecipitation and RNA isolation. In
parallel, the mRNP-tagging assay was used to sort messages
from FLAG-PABP VRP infected L929 cells by lysing the entire
monolayer, and using anti-FLAG immunoprecipitation to
isolate FLAG-tagged PABP-bound messages specifically from
the infected cells in the monolayer. To compare host mRNA
levels in each infected cell population, mock treated L929
monolayers also were lysed, and the PABP-bound mRNA
isolated by immunoprecipitation.
As shown by real-time PCR analysis (Figure 5), a substantial
induction of IFNb, IP-10, and IRF-1 mRNA in the L929
infected cell population over mock treated cells was apparent
following analysis of both the FACS-based or mRNP-tagging
Figure 3. RNA Profile Comparison following High MOI Infection
Changes in host gene expression were assessed following VRP infection, using RNA isolated by three distinct methods. L929 cells (106) were mock
treated or infected with FLAG-PABP VRP (MOI¼5). At 6, 12, or 24 h, cellular RNA was harvested by three separate methods: (i) Total RNA from mock and
VRP-infected cells was isolated using UltraSpec reagent. (ii) All mRNA bound to PABP in lysates prepared from mock and VRP-infected cultures were
isolated by anti-PABP immunoprecipitation. (iii) mRNA from infected cells was specifically isolated by anti-FLAG immunoprecipitation, recovering FLAG-
PABP bound RNA in VRP-infected lysates. The separate RNA populations served as input RNA in an RPA to analyze expression profiles of several host
genes. The fold induction of (A) IRF-1 and (B) IFNb are shown above, comparing the profiles generated from each isolation technique. For the mock
references, RNA was analyzed from mock treated cells using the corresponding isolation technique (e.g., signal from infected total RNA was compared
to mock total RNA, and infected IP RNA was compared to mock IP RNA). The data are a representative of two separate experiments, with each sample
internally normalized to GAPDH signal.
doi:10.1371/journal.ppat.0030199.g003
Figure 4. Sensitivity of the VRP mRNP-Tagging System
To assess the level of sensitivity in the mRNP-tagging system, an in vitro
experiment was performed to model the in vivo–like condition of a
diluted infected cell population. At 6 hpi, cell lysates (1 ml) were
prepared from 106 L929 cells that had been infected with FLAG-PABP
VRP (MOI¼5). The resulting lysates were mixed in decreasing ratios of
infected lysate to mock lysate, to a total volume of 200 ll. Anti-FLAG
immunoprecipitation was performed to isolate RNA from the infected
cell portion of this mixed lysate. To assess the mRNA signal recovered
from the infected cells, an RPA was used to detect several host mRNAs,
two of which are shown above (IRF-1, GAPDH). Signal from infected cell
RNA within the mixed lysate was detected in samples comprised of as
little as 1% infected cell lysate (highlighted by the small dots), a value
approximately equal to 2 3 103 infected cells. Quantitation of the IRF-1
signal can be found as supplementary data (Table S1, Figure S2).
doi:10.1371/journal.ppat.0030199.g004
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techniques. Importantly, in comparing the two methods, the
degree of sensitivity in detecting mRNA from the minority
population of infected cells using the tagging technique was
at least equal to (IFNb, IRF-1), if not enriched (.53 enrich-
ment in IP-10) in comparison to those generated by the
FACS-based method. These results further validate the
mRNP-tagging system as a powerful tool for the analysis of
changes in host gene expression following viral infection.
Utilizing VRP mRNP-Tagging in Dendritic Cells Provides an
In Vitro System for Studying Early Events in VEE
Pathogenesis
A major advantage in using VRP as opposed to VEE virus in
the mRNP-tagging system is the opportunity they provide to
study the earliest events in the course of VEE pathogenesis, as
VRP infect and replicate only within the first round of
infected cells. We have previously demonstrated that den-
dritic cells represent an important early target of infection in
vivo, as VRP target DCs at the site of inoculation following
footpad delivery in the mouse model [20], and have likewise
been shown to efficiently transduce human DCs in vitro [35].
In addition, several groups have examined DC-tropic proper-
ties for other alphaviruses, such as Sindbis virus [36–39] and
Ross River virus [40]. Primary murine bone marrow dendritic
cells were therefore chosen as an in vitro model system to
study early VRP-induced host responses.
To compare the host response profile following traditional
total RNA isolation of bone marrow–derived dendritic cells
(BMDCs) versus that generated using the mRNP-tagging
system, primary DCs isolated from 129sv/ev mice were
infected at an MOI of 0.5 with FLAG-PABP VRP. At this
MOI, approximately 4% of the cells are infected (see Figure
S3B). At 6 hpi, RNA was isolated from mock treated and VRP-
infected BMDC by either 1) preparing cell lysates for isolation
of PABP and FLAG-PABP bound mRNAs by immunopreci-
pitation, or 2) adding UltraSpec reagent for isolation of total
RNA. The mRNP-tagging method specifically isolated mRNA
from the infected cells using the bound FLAG-tagged PABP
marker, and this population of mRNA was compared to
endogenously PABP-bound messages in the mock BMDC
culture. In contrast, the traditional RNA isolation lacked this
discrimination, and therefore total cellular RNA was isolated
from the entire infected and mock treated BMDC cultures for
comparison.
As shown in Figure 6 (black bars), the gene expression
profiles (IFNb, IP-10, IL-6) evaluated specifically from the
infected cells of the BMDC culture using the mRNP-tagging
technique were dramatically enhanced in comparison to
profiles from the entire population of infected and unin-
fected DCs generated using total RNA. The fold induction of
IFNb, IP-10, and IL-6 mRNA in the infected BMDC cultures
were found to be approximately 20- to 200-fold higher than
that measured by total RNA (compare the black bars in
Figure 6). It is likely that the high proportion of uninfected
cells in the low MOI environment masked the signal from the
minority of infected cells when assayed from the total RNA
samples. Therefore only once these populations could be
assessed separately could the fundamental differences exist-
ing between the infected and uninfected cell responses be
revealed. All three of the evaluated defense response genes
were induced to high levels in the infected DCs at this early
timepoint of 6 hpi, suggesting that the host innate response is
rapidly initiated following VRP infection of BMDCs.
Although this rapid response could be detected in the DC
culture as a whole using the total RNA analysis, the mRNP-
tagging method was required to reveal the full extent of this
early defense response within the infected cell population.
In the Absence of IFNAR Signaling, the Defense Response
in Infected BMDCs Is Greatly Diminished
The contribution of the IFNab system in determining the
outcome and severity of VEE disease has been described for
over 30 years [41,42]. Therefore, in seeking to further
characterize the initial stages of VEE pathogenesis, the
interferon response was a primary target for study. Accord-
ingly, in the previous experiment, the host response to
infection in primary BMDC isolated from IFNab receptor
knockout (IFNabR/) animals also was analyzed at 6 hpi. We
hypothesized that in a system lacking IFNab receptor signal-
ing, the mRNP-tagging method of specifically profiling the
infected cell response should detect a diminished induction
in interferon-stimulated genes (ISGs), as the positive auto-
crine feedback signaling within these cells should be crippled
in the absence of the IFNab receptor. In this manner, the
IFNabR/ BMDC also provided another model system for
substantiating the VRP mRNP-tagging technique.
As demonstrated in Figure 6, the ISG response in the
infected IFNabR/BMDC (stippled bars) as measured by the
mRNP-tagging assay was much diminished in comparison to
the response in wildtype BMDC (black bars). The induction of
IFNb and IP-10 mRNA in the receptor knockout BMDC was
diminished by approximately 200- to 1,500–fold, respectively,
in comparison to levels of induction in the wildtype BMDCs.
Figure 5. Infected Cell Gene Expression Profiles Generated by mRNP-
Tagging versus FACS-Based Assays
The VRP mRNP-tagging approach and a FACS-based method of sorting
infected cells were compared. L929 cells (1.5 3 106) were infected with
either GFP-VRP or FLAG-PABP VRP (MOI¼0.2). Twelve hours after GFP-VRP
infection, infected cells were sorted and recovered based on GFP
expression via FACS. The recovered GFP-positive (infected) cells were
lysed, and all PABP-bound host messages were isolated by anti-PABP
immunoprecipitation. In parallel, 12 h after FLAG-PABP VRP infection, the
mRNP-tagging assay was used to directly sort the mRNA from infected
cells by anti-FLAG immunoprecipitation. To evaluate and compare host
gene expression in the infected cell populations, two independent
samples were analyzed for IFNb, IP-10, and IRF-1 expression by Taqman
real-time PCR. The results were normalized to GAPDH signal, compared
to PABP-bound mRNA from mock infected cells, and averaged.
doi:10.1371/journal.ppat.0030199.g005
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The IL-6 response also was reduced specifically in the infected
cells of the IFNabR/ BMDC culture as compared to the
wildtype IFNabRþ/þBMDC culture, with the induction of IL-6
message measured by the mRNP-tagging assay at only
background levels in comparison to mock treated IFNabR/
BMDC culture. Therefore, the host response in the absence
of IFNab receptor signaling did in fact demonstrate a
diminished induction of ISGs, specifically within VRP-
infected cells.
In contrast to the infected cell response, when the same
cultures were globally assayed for changes in gene expression
using total RNA analysis, the loss of the IFNab receptor in the
culture overall appeared to have little effect on ISG induction
at this early time post-infection (Figure 6). As compared to
mock treated cells, the induction of IP-10 and IL-6 mRNA was
similar in wildtype and interferon receptor knockout BMDC
when measured by total RNA at 6 hpi. However, following
VRP infection, IFNb total RNA message levels were found to
be approximately 5-fold higher in the IFNabR/ BMDC
culture in comparison to the wildtype BMDC culture. This
enhancement may be due in part to anti-viral paracrine
signaling induced in the uninfected cell majority in an IFNab
receptor-independent manner. It is important to note that in
analyzing this low MOI infection using only total RNA, the
high background of uninfected cells in the culture (;94% to
96% of the culture, Figure S3B) masked the dramatic effect
the receptor knockout had on host gene expression in the
infected cell population. The decreased host response of
IFNb, IP-10, and IL-6 message in the infected IFNabR/ cells
would have gone undetected had the mRNP-tagging system
not been utilized.
In Vivo, the Combination of mRNP-Tagging and
Traditional Profiling Reveals Dynamic Multifactorial
Interactions in the DLN
Previous studies by our group and others have examined
the succession of events characteristic of VEE pathogenesis in
the mouse model. Following inoculation in the footpad,
Langerhans-like cells infected at the site of inoculation in the
footpad subsequently migrate to the popliteal DLN [20]. It
has been hypothesized, based on these observations, that the
early events within the DLN set the stage for the specific
pattern of virus replication and host response characteristic
of VEE pathogenesis. Seeking to focus on the early
interactions of virus and host in the DLN, we extended our
characterization of the host response to the mouse model,
with the hypothesis that combining total RNA profiling with
the tagging system would generate a more comprehensive
view of the host response post-infection in vivo.
Adult BALB/c mice were inoculated in each rear footpad
with 106 IU of FLAG-PABP-VRP. At 6 h and 9 hpi, the
popliteal DLNs were removed and pooled. Subsequently,
either total RNA was isolated using the RNeasy Protect
protocol (Qiagen), or RNA specifically from the infected cells
was isolated by anti-FLAG immunoprecipitation. cDNA was
Figure 6. Role of Interferon Signaling in VRP-Induced Host Gene
Expression in Infected versus Bystander BMDC
BMDC (106) generated from wildtype 129sv/ev mice (black bars) were
infected with FLAG-PABP VRP at a low MOI (0.5). At 6 h, RNA was isolated
from mock and VRP-infected BMDC by either 1) preparing cell lysates for
isolation of FLAG-PABP-bound mRNA via anti-FLAG immunoprecipita-
tion, or 2) using UltraSpec reagent to isolate total cellular RNA. The
mRNP-tagging method specifically isolated mRNA from the minority of
infected BMDC via the bound FLAG-PABP. Conversely, total RNA
extraction was used to isolate cellular RNA from the entire VRP-infected
BMDC culture, with the majority of the population being DCs that had
not been infected. To examine the contribution of signaling through the
IFNab receptor, the same analysis was carried out in BMDC derived from
IFNabR/ mice (hatched bars). cDNA was generated from each RNA
isolation, and assessed for changes in host gene expression by Taqman
real-time PCR. Three independent samples were normalized to GAPDH
signal and analyzed in comparison to mock infected BMDC: Infected cell
anti-FLAG(PABP) signal was compared to mock PABP signal, and infected
total RNA signal was compared to mock total RNA signal. The data are
shown as the geometric mean, 6 the standard error of the mean.
doi:10.1371/journal.ppat.0030199.g006
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synthesized from each RNA sample, and Taqman real-time
PCR was performed to analyze several target host genes. Two
independent DLN samples were analyzed from each group,
with GAPDH serving as the internal housekeeping control
gene. The expression profiles of three host messages (IFNb,
IP-10, and IL-6) characterized from the DLN post-infection
are shown in Figure 7. Two distinct views of the response to
infection in the DLN were revealed; the global host response
in the DLN as a whole, and the specific response within the
infected cell population.
In examining the response to infection over time within
the infected cells, an early robust expression of IFNb and IP-
10 was exhibited in the anti-FLAG isolated RNA at 6 hpi,
which waned by 9 hpi. This suggests a very rapid response to
VRP infection within infected cells of the DLN. While the
response was waning between 6 and 9 hpi within the infected
cells, the total RNA profile of the DLN demonstrated that the
response in the organ as a whole was increasing during this
time interval. By 9 hpi, the majority of the IFNb and IP-10
host response appears to have shifted to the surrounding
uninfected cells of the DLN. This is likely due to a robust
activation of the innate immune response directly within the
infected cells, which then induces mediators (e.g., cytokines)
that are released into the surrounding environment of the
DLN to initiate paracrine responses in neighboring unin-
fected cells. This detailed view of events occurring at early
times post-infection has been difficult, if not impossible, to
examine previously.
The IL-6 host response presents an interesting scenario, as
there was a complete lack of signal detected at 6 hpi in the
infected cells of the DLN as measured by the mRNP-tagging
system (Figure 7, asterisk). However there was a robust IL-6
response measured at 6 hpi from the total RNA isolated from
the entire DLN. This suggests that the infected cells of the
DLN are not the main producers of IL-6 initially following
VRP infection. Instead, the uninfected bystander cells may be
particularly poised to respond to paracrine signals from
infected neighboring cells, resulting in IL-6 expression. By 9
hpi, IL-6 expression was detected in both the infected cell
population as well as in the DLN as a whole, indicating a
continuation of the dynamic interplay between the infected
and uninfected cells in this environment. This two-phase
innate response would have otherwise gone undetected had
the mRNP-tagging technique not been integrated with the
traditional profiling, allowing for a uniquely multifaceted
examination of the VRP-infected host.
Discussion
Here we have introduced an innovative approach for
assessing gene expression changes following viral infection in
vitro and in vivo, addressing a critical parameter that has been
difficult, if not impossible, to address previously. By distin-
guishing changes in the host transcriptional program of
infected cells from that of uninfected bystander cells, the
mRNP-tagging technology provides an important advance-
ment in gene expression profiling, and promises to increase
Figure 7. In Vivo, the Combination of Traditional Profiling and mRNP-
Tagging Uncovers Dynamic Gene Expression Changes within the DLN
Adult female Balb/c mice were inoculated in both rear footpads with 106
IU of FLAG-PABP VRP. Mock treated animals were inoculated with diluent
alone. At 6 and 9 h, the popliteal DLNs were removed and washed with
PBS. To isolate RNA from the entire cellular population of the DLN, both
DLNs were pooled, homogenized, and total RNA extracted. For isolation
of mRNA specifically from the infected cells of the DLN, the mRNA
tagging technique was used: Five DLNs were pooled per sample and
homogenized in lysis buffer, followed by anti-FLAG immunoprecipita-
tion. cDNA was synthesized from each RNA sample, and Taqman real-
time PCR was performed against several target host genes. Two
independent pools were analyzed from each group, with GAPDH serving
as the internal housekeeping control gene. Infected cell anti-FLAG (PABP)
signal was compared to mock PABP signal, and infected total RNA signal
was compared to mock total RNA signal. The results from each
independent pool are graphed side-by-side. Asterisks indicate samples
from infected DLN that had no detectable signal following anti-FLAG
immunoprecipitation. mRNP-tagging analysis in conjunction with tradi-
tional profiling reveals two distinct, comprehensive views of the
response to infection within this target tissue in vivo.
doi:10.1371/journal.ppat.0030199.g007
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our understanding of the host response to virus infection,
particularly in vivo.
Characterization of the VRP mRNP-tagging approach has
demonstrated several key aspects of the system. First and
foremost is the ability of the system to effectively target and
isolate mRNA from the infected cell population. In high MOI
cell culture experiments, where all cells are infected, the gene
expression profiles generated from total RNA and RNA
isolated by mRNP-tagging were similar. Additionally, in low
MOI cell culture experiments, where only a minority of cells
(;10%) are infected, the RNA profiles generated from the
infected cell population isolated by FACS were similar to the
gene expression profiles isolated by the mRNP-tagging
technique without prior cell sorting. These results demon-
strate that mRNP-tagging yields profiles that are representa-
tive of infected cells, even when they are the minority cell
population.
An equally important aspect of the mRNP-tagging system is
that the method is sensitive. In mixing experiments, where
the infected cell signal was diluted with mock lysate, the
mRNP-tagging approach detected a unique transcriptional
profile when as few as 1% of the cultured cells were infected.
Moreover, the sensitivity of directly isolating infected cell
mRNA via the mRNP-tagging approach proved to be as great,
or even enhanced in comparison to analysis of message levels
when isolated from infected cells following a commonly
utilized FACS-based approach. This ability to effectively
analyze a small minority of infected cells, such that the mRNA
signal from infected cells is no longer masked by the
background of uninfected cells, is a property well suited for
application in vivo.
Additionally, the VRP mRNP-tagging technique allows this
level of specificity without harsh treatment of the infected
cell populations prior to RNA isolation. This is in contrast to
FACS analysis, which commonly requires physical manipu-
lation of cultured cells or tissues (e.g., trypsinization,
collagenase digestion), and may result in cellular damage to
delicate cell types analyzed post-infection, such as the
shearing of fragile dendrites from the cell body of DCs. This
physical manipulation may affect the host gene expression
profile of cells, similar to the profound effects various
isolation techniques can have on the maturation and function
of DCs [43]. However, since the VRP mRNP-tagging system
isolates mRNA from infected cells following lysis directly in
the culture vessel or from intact tissue, the cells are not
distressed prior to message isolation and may more accu-
rately reflect the host transcriptional program at the time of
isolation.
Furthermore, avoiding manipulations that result in a long
lag time between cells/tissue harvest and RNA isolation may
be particularly advantageous when dealing with relatively
unstable messages. The finding of 5-fold higher levels of IP-10
by the mRNP-tagging technique in Figure 5 may reflect such a
situation. It is possible that the difference in IP-10 signal
sensitivity between the GFP-VRP infected group and the
FLAG-PABP VRP infected group may be a manifestation of
the stability of the IP-10 message versus the other messages
examined. In fact IP-10 message has been documented to be
relatively unstable and to increase in stability when mRNA
binding proteins are bound to it [44]. Lysing and analyzing
the infected cell IP-10 message directly from the culture
vessel by the mRNP-tagging method may have allowed us to
increase the sensitivity in detecting an unstable message. It is
also worthy to note that given the well-established roles for
PABP in translation initiation and mRNA stability [5,7,8,45],
PABP-associated mRNA may actually be more representative
of the cell’s actively translated message population or the
proteome [1,13].
Application of the mRNP-tagging method has revealed
several important insights into the host innate response to
virus infection. First, the host response is dramatically
different in infected and uninfected cells within the same in
vitro cell culture or the same tissue in vivo, varying in
quantitative, qualitative and temporal terms. Quantitatively,
the level of response in each population varied by gene,
indicating that the transcriptional programs of infected and
uninfected cells within the same culture or tissue are uniquely
affected. On a gene by gene basis, comparing the infected cell
profile generated by the mRNP-tagging system to the total
RNA profile generated from the entire culture or tissue
allows the relative contribution of the infected versus
uninfected cell populations to be teased apart. In the case
where a small percentage of primary BMDC were infected in
vitro, the induction of IFNb, IP-10, and IL-6 in infected cells as
measured by the mRNP-tagging system was up to 200 times
that indicated in the total RNA sample for the entire culture.
These results suggest that the infected cells may be the
primary source of the early IFNb, IP-10, and IL-6 response to
VRP infection in BMDC cultures.
Additionally, had the mRNP-tagging system not been
utilized, the induction of IL-6 would likely have been
overlooked due to the low total RNA induction measured
from the BMDC culture. Therefore, at particular times the
level of response in the infected and uninfected cell
populations can differ so extensively that their analysis
becomes qualitatively different. In other words, a response
that is robust in one population may be completely absent in
the other, and in this regard, the host response will appear to
be quite different when evaluating infected cells alone rather
than the entire culture or tissue.
Temporally, the combination of the mRNP-tagging ap-
proach and total RNA analysis offered a unique vantage point
into the kinetics of the infected and uninfected cell
responses. In the DLN, this analysis demonstrated two phases
of the innate host response. The first apparent phase was a
rapid response in the infected cells of the DLN, including the
robust activation of key host defense genes, IFNb and IP-10, at
6 h following footpad inoculation. While this infected cell
response was waning by 9 hpi, an apparent second phase of
response was mounting in the surrounding uninfected cells of
the DLN, with induction of the same defense genes increasing
from 6 h to 9 hpi. In fact, a similar rapid onset of the host
innate response has been described previously following
virulent VEE infection, with cytokine RNA levels in the DLN
of infected mice peaking at 6 to 12 h following footpad
inoculation, and waning by 24 to 48 h [46]. However, the use
of VRP and the application of the mRNP-tagging system in
our study provided the ability to distinguish the events
specifically occurring within the first round of infected cells
in vivo from the effects on the uninfected bystander cells of
the DLN, as well as from the complication of viral cell-to-cell
spread, revealing the unique kinetic response to infection
occurring in each population.
Several signaling events are likely to contribute to the
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kinetics of this two-phase activation. Replicon particle bind-
ing, entry, and replication provide a multitude of signals to
initiate the early host defense response directly within the
infected cells. It is likely that the rapid innate activation of
the infected cell population leads to the secretion of
cytokines and other soluble immune modulators. A portion
of these mediators likely initiate the cell signaling events in
uninfected bystander cells that are responsible for the strong
paracrine response in the DLN at later times post-infection.
This would include the activation of cells which have homed
to the DLN as an active site of viral infection. In fact, a large
influx of cells to the DLN has been observed following
footpad VRP inoculation, including cells of the proinflam-
matory response and antigen presenting cells (J. M. Thomp-
son, A. C. Whitmore, J. L. Konopka, T. P. Moran, and R. E.
Johnston, unpublished data). These recruited cells would
remain uninfected, but would be susceptible to the primed
environment of the DLN, and likely contribute to the
induction of the second phase of the host innate response
in vivo.
Our results highlight the role of the innate immune
response during VEE infection, particularly the interferon
response. Evidence for the major role of the interferon system
in controlling VEE replication and spread in vivo has been
well established [18,19,23,40–42,47–49], with tremendous
levels of soluble, biologically active interferon in the serum,
measured at up to 80,000 IU/ml following virulent VEE
infection [18]. The absence of interferon signaling in vivo
results in a significantly shorter average survival time
following VEE infection (30 h in mice lacking the IFNab
receptor in comparison to 7.7 days in wildtype mice), and a
10,000-fold increase in virus titers [18]. Here, the role of the
interferon response in autocrine and paracrine signaling of
infected and uninfected cells was further elucidated in BMDC.
While ablating the IFNab receptor had no apparent effect on
the total RNA induction of IFNb, IP-10, and IL-6 genes in the
BMDC culture as a whole, a dramatically reduced induction of
each of these host response genes was observed in the infected
BMDC population. This strongly suggests that autocrine
signaling through the IFNab receptor on the infected cells
plays a critical role in inducing a strong ISG response.
Conversely, in the uninfected BMDC population, the
absence of IFNab receptor signaling had little effect on the
induction of the same host response genes, remaining at near
wildtype levels. This was a surprising, nonetheless interesting
result that suggests interferon-mediated signaling through
the IFNab receptor is not the primary paracrine mediator
leading to the induction of these particular host response
genes in uninfected bystander cells. It is important to
highlight the fact that this data does represent a temporal
snapshot of the host response at the early time of 6 h post
VRP infection. However, it is consistent with previous
findings showing levels of biologically active type 1 serum
interferon are similar in IFNab receptor knockout and
wildtype mice at early times post VRP infection [18].
Together, these data suggest that at least early in infection,
VRP may induce an interferon response mediator that is
independent of type 1 receptor signaling, such that
surrounding uninfected cells lacking the type 1 receptor are
still capable of mounting an antiviral response. It is
important to note that BMDC lacking the type 1 interferon
receptor are more permissive to infection with VRP than
wildtype BMDC (Figure S3B), which may result in increased
levels of transgene expression (Figure S3C), and may in part
contribute to the higher induction of IFNb in the receptor
knockout BMDC demonstrated in Figure 6. Such factors will
need to be addressed should a separate line of investigation
be initiated to explore the identity of this novel mediator(s).
Taken together, the data presented here highlight an
important additional observation. Namely, reductionist in
vitro approaches do not always recapitulate what is occurring
in vivo. Often, high multiplicity infections of largely homo-
genous cultured cells are utilized in vitro to draw conclusions
about what occurs in naturally low multiplicity infections of
complex heterogeneous tissues in vivo. However, the data
presented here strongly argue that the naturally heteroge-
neous environment of infected and uninfected cells existing
during infection in vivo must be appreciated in order to
understand the dynamic interactions occurring between
these populations. For example, here in cultured BMDC, IL-
6 was highly induced in VRP infected cells at 6 hpi. However,
this did not appear to be the case in vivo where induction of
IL-6 mRNA was first documented in the uninfected bystander
population.
The application of the VRP mRNP-tagging system offers a
multitude of future studies that promise unique perspective
on the highly coordinated host response to viral infection.
However, it is worthwhile to note that there is room for
potential improvement to the overall VRP mRNP-tagging
platform. As it stands currently, the mRNP-tagging system
specifically grants a temporal snapshot of the infected cell
response—a response that differs not only quantitatively but
also qualitatively from that of the bystander uninfected cells
and from the culture as a whole. While this is a key strength,
in this initial application of the system we relied on total RNA
isolated by a separate technique to evaluate the ‘‘uninfected
cell’’ response. This was possible given an underlying
condition of low MOI infections, in that the majority of cells
in a given culture or tissue would be uninfected. In evolving
the system from here, a major goal will be to achieve a way to
more directly compare host RNA responses from uninfected
and infected cells in the same culture or tissue. Nonetheless,
even as it stands at this current stage, the mRNP-tagging
system provides a powerful way to address the dynamic
interaction of pathogen and host.
A critical future application of the VRP mRNP-tagging
system will be the analysis of the host response to infection
within the brain, where the most extensive pathogenesis is
observed following VEE virus infection. While alphavirus
CNS pathogenesis has been studied extensively in several
model systems, it has been suggested that multiple host- and
virus-specific parameters contribute to VEE-induced pathol-
ogy in the brain [50–52]. In elucidating such parameters,
distinguishing the relative contribution of infected versus
bystander cells in the CNS has proven critical following
infection with neuroadapted Sindbis virus [53,54], and is also
likely to be crucial in understanding VEE-induced neuro-
degeneration. Developing the mRNP-tagging system using
VEE virus with a double 26S subgenomic promoter would
also facilitate the characterization of the host response to
VEE infection downstream of the DLN, including the impacts
of virus budding as well as cell-to-cell spread during infection
[20].
The application of mRNP-tagging technology to the study
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of the host response to viral infection opens avenues of
investigation that have previously been difficult to navigate. A
better understanding of virus–host interactions may sub-
sequently facilitate the design of improved therapeutics and
vaccines. More specifically, gaining a clear profile of the host
response to VEE infection promises to further our under-
standing of the specific virus–host interactions that define
alphavirus pathogenesis in vivo.
Materials and Methods
VEE replicon particles (VRP). The construction and packaging of
VRP using a split helper system have previously been described [33].
The replicon plasmid constructs used in this study were (i) replicons
expressing green fluorescent protein (GFP-VRP) and (ii) replicons
expressing an N-terminally FLAG-tagged version of poly(A) binding
protein I (FLAG-PABP VRP). The production of GFP-VRP has been
described previously [20,55]. The FLAG-PABP replicon plasmid was
generated by the directional cloning of the ORF of PABP I containing
an N-terminal FLAG epitope tag (GACTACAAGGACCACGATGA-
CAAG, kindly provided by J. D. Keene [14]), immediately downstream
of the 26S mRNA promoter of the pVR21 replicon plasmid.
All replicon particles used in this study were packaged in the
wildtype (V3000) VEE envelope [33]. Briefly, the replicon RNA
genome containing the VEE nonstructural genes and expressing the
heterologous gene from the viral 26S promoter, along with two
defective helper RNAs providing the wildtype capsid and glycopro-
tein genes, but lacking the virus-specific packaging signal, were co-
electroporated into BHK-21 cells (ATCC). Due to the lack of encoded
viral structural genes in the replicon genome, infectious VRP
undergo only one round of infection, and the absence of propagating
recombinant virus was confirmed by passage in BHK-21 cells. VRP
were concentrated from supernatants by centrifugation through a
20% sucrose cushion and resuspended in PBS. BHK-21 titers were
determined either by immunofluorescence (GFP-VRP), or immuno-
cytochemistry (null VRP, FLAG-PABP-VRP) using sera containing
antibody to the VEE nonstructural proteins.
Cells and in vitro infections. (i) Infection of L929 cells. L929 murine
fibroblasts (ATCC) were maintained at 378C under 5% CO2 in
complete alpha minimal essential medium (aMEM, Gibco) containing
10% donor calf serum, 10% tryptose phosphate broth, 2 mM L-
glutamine, 100 U/ml penicillin and 0.5 mg/ml streptomycin. For VRP
infection, 106 cells were seeded in 60 mm dishes and incubated
overnight. The medium was removed from the monolayer and the
cells were infected at a multiplicity of infection (MOI) of 5 (unless
otherwise indicated) in 0.2 ml endotoxin-free PBS supplemented with
110 mM Ca2þ, 50 mM Mg2þ, and 1% vol./vol. donor calf serum. After 1
h of adsorption at 378C, complete aMEM was added to the monolayer.
In studies involving the pretreatment of L929 cells with AMD to
inhibit the transcription of new host RNA, cells were pretreated with
4 ug/ml AMD for 1 h prior to VRP infection.
(ii) Generation of primary murine BMDCs. Breeding pairs of IFNabRþ/þ
129Sv/Ev and IFNabR/ mice were kindly provided by Herbert
Virgin (Washington University, St. Louis, MO) and Barbara Sherry
(North Carolina State University, Raleigh, NC), respectively. Mice
were bred under specific pathogen-free conditions in the Depart-
ment of Laboratory Animal Medicine breeding colony facilities at the
University of North Carolina, Chapel Hill. To generate primary
immature BMDCs [40,56], bone marrow cells from femurs and tibia of
8- to 14-week-old mice were aspirated with RPMI-10 medium (RPMI
1640 [Gibco], 10% FBS, 2 mM L-glutamine, 50 uM 2-ME, 100 U/ml
penicillin, 100 ug/ml streptomycin sulfate). Cells were filtered through
a 40 um cell strainer, pelleted, and resuspended in lysis buffer (0.15 M
NH4Cl, 0.1 mM Na2EDTA, 1 mM KHCO3 [pH 7.2–7.4]). Following lysis
of red blood cells at room temp, 10 ml of RPMI-10 media/mouse was
added, cells were again pelleted and resuspended in fresh RPMI-10
media. Cells were seeded in 6-well low cluster plates (Corning) in
RPMI-10 media supplemented with 20 ng/ml GM-CSF (Peprotech),
and incubated at 378C under 5% CO2. On day three, RPMI-10 media
supplemented with 20 ng/ml GM-CSF and 20 ng/ml IL-4 (Peprotech)
was added to each well. On day five, additional RPMI-10 media
supplemented with 10 ng/ml GM-CSF and 10 ng/ml IL-4 was added to
each well. On day seven, the BMDC were harvested and either
immediately used for infection, or were cryopreserved at 2–53106/ml
in 90% FBS/10% DMSO.
(iii) Infection of primary BMDCs. Cryopreserved BMDCs were quickly
thawed in a 378C water bath, and gently transferred to a conical tube
containing an equal volume of RPMI-10. The volume of RPMI-10 was
brought up to 10 ml, and the cells were pelleted. An additional wash
with RPMI-10 was completed, and the cells were resuspended in
RPMI-10, supplemented with 5 ng/ml GM-CSF and IL-4. BMDCs were
seeded at 2.5 3 106 cells/well in hydrated six-well low cluster plates,
and allowed to recover overnight at 378C, 5% CO2. BMDCs were
harvested and pooled with a cold PBS wash of each well. After
pelleting, cells were resuspended at 106 cells/ml, and 106 cells/well
were seeded in a hydrated six-well low cluster plate. BMDC were
infected with VRP at an MOI of 0.5 in 100 ul PBS supplemented with
1% donor calf serum and Caþ/Mgþ. Following 2 h of absorption at
378C, 5 ml of RPMI-10 supplemented with 5 ng/ml GM-CSF and IL-4
was added to each well.
Animals and in vivo infections. Seven- to eight-week-old female
BALB/c mice were obtained commercially (Charles River Laborato-
ries) and allowed to acclimate for 5–7 days. Mice were inoculated in
each rear footpad with 106 IU of VRP diluted in 10 ul endotoxin-free
PBS containing 1% donor calf serum. Mock-infected animals
received diluent alone.
Total RNA isolation. (i) L929 cells. At indicated times post-
infection, media was removed and L929 cell monolayers were washed
with cold PBS. The UltraSpec RNA Isolation System was used to
isolate total RNA, with 1ml of UltraSpec RNA Reagent added to each
60mm dish of L929 cells per manufacturer’s protocol (Biotecx).
(ii) Primary BMDCs. At 6 or 12 hpi, BMDCs were transferred to a 15
ml conical tube and pelleted (1,200 rpm, 10 min at 48C), during which
time each well was washed with cold PBS. The wash was used to
resuspend the pelleted cells, followed by a second spin. Total RNA
was harvested from BMDC using the RNeasy Mini Kit, according to
the manufacturer’s protocol (Qiagen).
(iii) Lymph nodes. At indicated times post infection, mice were
euthanized and both draining popliteal lymph nodes were harvested,
washed with cold PBS, and pooled together into 200 ul RNAlater RNA
Stabilization Reagent (Qiagen, Ambion). Total RNA was harvested
from tissue homogenate prepared using a plastic pestle with a
handheld motor and the RNeasy Protect Mini Kit (Qiagen).
mRNA-tag immunoprecipitation and RNA isolation. (i) Antibodies.
The mRNP-tagging method as applied to cells and animal tissues
infected with VRP was developed from general ribonomics/mRNP-
tagging protocols previously described by the Keene laboratory
[1,2,9,14]. Polyclonal anti-PABP antibody was generously provided by
J. Keene (Duke University Medical Center). Additionally, polyclonal
anti-PABP H-300 antibody was obtained from Santa Cruz Biotech-
nology. Monoclonal anti-FLAG M2 antibody was acquired from
Sigma-Aldrich.
(ii) Preparation of mRNP lysate from cultured cells. L929 monolayers (106
cells total) were washed with cold PBS, followed by lysis of the
monolayer with 1ml of polysome lysis buffer (100 mM KCl, 5 mM
MgCl2, 10 mM Hepes [pH 7.0], and 0.5% Nonidet P-40 with 1 mM
DTT, 100 U/ml RNaseOUT [Invitrogen], 0.2% vanadyl ribonucleoside
complex [New England Biolabs], and 1 tablet/10 ml Complete Mini
Protease Inhibitor Cocktail Tablet [Roche] added fresh at time of
use). For BMDC lysis, cells were gently pelleted and the media
removed. The pellet was washed with PBS and spun again, followed by
resuspension and lysis in 500 ul of polysome lysis buffer. Cells were
lysed for 10 min, followed by centrifugation at 14,000g in a tabletop
microfuge for 10 min at 48C to remove cellular debris. The ;1 ml
total volume of L929 mRNP lysate (isolated from 106 L929 cells) was
stored at 808C in 200 ul working aliquots, while the 500 ul total
volume of BMDC mRNP lysate (isolated from 106 BMDC cells) was
stored at 808C in 250 ul working aliquots.
(iii) Preparation of mRNP lysate from whole animal tissue (DLN). Freshly
dissected DLN were washed with ice-cold PBS. Five DLN were pooled
per sample, and coarsely homogenized in 200 ul polysome lysis buffer
(containing RNase and protease inhibitors as described above) using a
plastic pestle and hand-held motor. Samples were frozen at 808C
until use. Upon thawing (on ice), the homogenization and lysis was
continued to completion (as monitored microscopically), and the
lysate spun at 48C to pellet any remaining tissue/debris. The
supernatant was transferred to a fresh tube on ice, and a second
round of lysis/ homogenization was completed on the pellet using 100
ul polysome lysis buffer. Upon centrifugation, this supernatant was
pooled with the first (;300 ul total) and kept on ice until use.
(iv) mRNP immunoprecipitation. For each immunoprecipitation
sample, two 60 ul aliquots of protein beads were prepared; the first
aliquot to coat with the specified antibody, and the second to pre-
absorb the lysate for removal of non-specific binding. For antibody
coating, 60ul Protein-A Sepharose beads (pre-swollen with 12ml PBS/
1.5g beads, Sigma) or fast flow Protein-G Sepharose beads (commer-
cially pre-swollen, Sigma) were washed with PBS (10 volumes),
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followed by a second wash of 10 volumes NT2 buffer (50 mM Tris [pH
7.4], 150 mM NaCl, 1 mM MgCl2, 0.05% Nonidet P-40) tumbled end-
over-end for 15 min at room temperature. Beads were resuspended in
10 volumes fresh NT2 buffer supplemented with 5% BSA, and
tumbled overnight at 48C with excess immunoprecipitating antibody
(200 ul anti-PABP antibody; 25 ul anti-FLAG antibody). Prior to the
immunoprecipitation reaction, the antibody-coated beads were
washed with 1 ml NT2 buffer.
To pre-absorb the lysate, a second 60 ul aliquot of beads (per
sample) was prepared as described above through the 15 min NT2
buffer wash. These beads were resuspended in 5–10 volumes NT2
buffer supplemented with 100 U/ml RNaseOUT, 0.2% vanadyl
ribonucleoside complex, 2 mM DTT, and 25 mM EDTA. The mRNP
lysate was added (;200 ul L929 lysate, 250 ul BMDC lysate, or 300 ul
DLN lysate), along with 1 ul normal animal serum corresponding to
the immunoprecipitating antibody (normal mouse serum for anti-
FLAG immunoprecipitation samples; normal rabbit serum for anti-
PABP immunoprecipitation samples). Samples were tumbled at room
temperature for 1 h to remove any material that would non-
specifically bind to the beads. This pre-absorbed lysate was recovered
by gently pelleting the beads and applying the supernatant to the
specific antibody-coated beads, along with 5–10 volumes of NT2
buffer supplemented as described above. This immunoprecipitation
slurry was tumbled end-over-end at room temperature for 2 h.
(v) RNA extraction from immunoprecipitated mRNP complex. Immuno-
precipitated samples were gently centrifuged to pellet the beads, and
washed four times with ice-cold NT2 buffer (10 bead volumes).
Washed beads were resuspended in 600 ul proteinase K digestion
buffer (100 mM Tris [pH 7.5], 12.5 mM EDTA, 50 mM NaCl, 1% SDS),
plus 25 ul of 20 mg/ml proteinase K, and incubated for 30 min in a
rotating device at 508C. 600 ul phenol-chloroform-isoamyl alcohol
(Fisher) was added to the beads, which were vortexed for 2 min and
then centrifuged for 5 min at 14,000g, 48C. This was followed by
extraction with one volume of RNA-grade chloroform (Fisher), and
standard isopropanol precipitation including 8 ul of glycogen. The
samples were stored at 808C until use for gene expression analysis.
Upon thawing on ice, the samples were spun for 30 min (14,000g, 48C),
and the RNA pellet washed with 100 ul of 80% ethanol. The RNA
pellet was resuspended in RNase-free water (Ambion), or hybrid-
ization buffer as necessary.
RNase protection assay (RPA). RNase protection assays were used
to determine the relative abundance of specific cellular mRNAs in
infected and mock infected L929 cells. 32P-labeled RNA probes were
synthesized by use of the RiboQuant in vitro transcription kit and a
RiboQuant multiprobe custom template set (BD Pharmingen). This
custom set included template for the synthesis of radiolabeled probes
specific to murine interferon beta (IFNb) and interferon regulatory
gene-1 (IRF-1), as well as mRNAs encoding the murine housekeeping
proteins GAPDH and L32. RNA isolated from the mRNP complexes
was used as input RNA for the mRNP-tagging samples, using 100% of
the isolated RNA by resuspending the RNA pellet directly in
hybridization solution. 2 ug of total RNA to be used as input samples
for total RNA analysis was isolated as described above. The custom
probe set was mixed with each RNA sample, placed in a pre-warmed
heat block at 908C which was immediately turned down to 568C, and
incubated overnight. The RNA-probe mixtures were treated with
RNase according to the RiboQuant RPA kit protocol (BD Pharmin-
gen). The protected dsRNA species were electrophoresed on a 4.5%
polyacrylamide-8M urea sequencing-sized gel, the gels were dried,
and analysis conducted on a Molecular Dynamics Storm phosphor-
imager with ImageQuant software. Values represent the fold change
over mock expression, as normalized to anti-PABP immunoprecipi-
tated GAPDH housekeeping mRNA levels for the mRNP-tagging
samples, or total GAPDH housekeeping RNA levels for total RNA
samples.
Western blotting. NP-40 protein lysate preparations were sepa-
rated by 8% SDS-PAGE, and transferred to polyvinylidene difluoride
membrane at 10 V for 60 min in transfer buffer (48 mM Tris, 39 mM
glycine, 10% methanol). The membranes were blocked overnight in
5% dry milk in TBST (50 mM Tris-HCl [pH 7.4], 150 mM NaCl, and
0.1% Tween 20), followed by incubation for 1h with either anti-PABP
(Santa Cruz Biotechnology, sc-28834) or anti-FLAG (Sigma-Aldrich,
F3165) primary antibody diluted in 1% dry milk-TBST. The
appropriate horseradish peroxidase (HRP)-conjugated secondary
antibodies (Amersham Pharmacia) were then added and incubated
for 1 h, followed by chemiluminescence detection using ECL
detection reagents (Amersham Pharmacia). Blots were exposed to
film and developed.
Flow cytometry analysis. For quantification of VRP infectivity and
26S transgene expression levels, GFP-VRP or mock infected cells
(BHK, L929, or BMDC) were harvested at 12 hpi, and washed once
with cold PBS. The cells were fixed with PBS/1% paraformaldehyde
before FACS analysis. FACS data were acquired using a Dako CyAn
Flow Cytometer and analyzed using Summit software (Dako).
To compare the infected cell host message profile generated by the
mRNP-tagging approach versus FACS-facilitated sorting, 1.5 3 106
L929 cells were mock treated or infected at a low MOI of 0.2 with
either FLAG-PABP VRP or GFP-VRP. At 12 hpi, cultures were treated
in one of two ways to generate a profile of host message levels
specifically from the infected cells. The cell monolayers that had been
infected with FLAG-PABP VRP were lysed, and FLAG-tagged host
messages were immunoprecipitated from the infected cells per the
mRNP-tagging protocol described above using 100% of the mono-
layer lysate. A separate anti-PABP immunoprecipitation was com-
pleted from both mock- and FLAG-PABP VRP-infected cell lysates to
isolate all PABP-associated mRNA and served as the mock reference
with normalization to GAPDH signal levels.
To generate a comparative profile of the infected cell host
response, cell monolayers that had been infected with GFP-PABP
VRP were prepared for FACS-based analysis. The monolayers were
trypsinized, washed with media (aMEM supplemented with 2% FBS,
100 U/ml penicillin, and 0.5 mg/ml streptomycin) and resuspended in
700 ul of fresh media. The UNC-CH Flow Cytometry Core Facility
provided cell sorting capability using the Dako Modular Flow (MoFlo)
Cell Sorter, gating on GFP-positive signal to sort and recover the
infected cell population. This GFP-positive cell population was gently
pelleted and resuspended in 0.5 ml polysome lysis buffer. 100% of the
resulting lysate was immunoprecipitated with anti-PABP antibody to
isolate all PABP-associated messages specifically from the (GFPþ
sorted) infected cell population. A separate anti-PABP immunopre-
cipitation was completed from mock cell lysate and served as the
mock reference with normalization to GAPDH signal levels. The host
message populations isolated from each technique were analyzed
using Taqman real-time PCR (see below).
cDNA synthesis, real-time PCR, and analysis. (i) cDNA synthesis. A
one-tube DNase treatment and reverse transcription protocol was
used to generate cDNA, using SuperScript III Reverse Transcriptase
First Strand cDNA kit (Invitrogen). 0.5–0.75 ug of either mRNA-tag
isolated or total RNA served as input RNA for the reaction, using
RNase-free water to bring the total volume to 10 ul. This was
combined with 1 ul 10 mM dNTP mix (Amersham Biosciences), 4 ul
5X SuperScript III reverse transcriptase buffer, 1 ul 0.1 mM dTT, 1 ul
40 U/ul RNaseOUT (Invitrogen), and 1 ul RQ1 RNase-free DNase
(Promega). The samples were DNase treated at 378C for 30 min,
followed by the addition of 1 ul RQ1 Stop Solution (Promega) and
heat inactivation of the samples at 658C for 10 min. Following the
addition of random hexamer primers (150 ng, Invitrogen), reverse
transcription of the samples was continued in the same tube,
according to the SuperScript III protocol (Invitrogen). cDNA samples
were stored at 208C.
(ii) Real-time PCR. Real-time PCR was performed to determine the
relative abundance of specific cellular mRNAs in infected and mock
treated samples. Taqman Gene Expression Assays (Applied Biosys-
tems) containing primers and probes for various target host messages
were used, with each reaction performed in a 25 ul total volume (5 ul
cDNA, 12.5 ul TaqMan Universal PCR Master Mix without AmpErase
UNG [Applied Biosystems], 1.25 ul probe/primer mix [Applied
Biosystems], and 6.25 ul RNase-free water). The default amplification
profile was performed by the ABI Prism 7000 Real-Time PCR System,
and the data converted into cycle threshold (CT) values by the 7000
Sequence Detection Software (v1.2.3, Applied Biosystems). Duplicate
samples were amplified from each experimental group with GAPDH
serving as the housekeeping control along with each target gene of
interest. A negative template control also was performed, with all
samples run in parallel on the same plate.
(iii) Total RNA real-time PCR analysis. Real-time PCR results are
presented as fold gene expression in the infected sample over that in
the mock sample, as normalized to the GAPDH housekeeping gene.
During each reaction, a cycle threshold (CT) value was generated for the
target gene of interest (and GAPDH), corresponding to the cycle
number at which the fluorescence of the PCR product reached
significant levels above the background threshold level. Raw CT values
generated from total RNA samples were analyzed using the well
established delta CT (DCT) method to generate the fold expression
results (User Bulletin, ABI Prism 7000 Sequence Detection System
[Applied Biosystems]). Briefly, for each cDNA sample, the GAPDH CT
value was subtracted from the CT value of the target gene (e.g., cytokine)
of interest, yielding a DCT value. The DCT value generated for the VRP-
infected sample was then subtracted from the DCT value of the mock
sample, yielding a DDCT value. This widely-used method assumes the
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target and housekeeping genes were amplified with the same efficiency,
thus the increase in host mRNA levels in the infected samples
compared to the mock treated samples was calculated as 2(DDCT ).
(iv) Real-time PCR analysis of mRNA-tagging samples. Prior to this
standard DCT analysis, raw CT values generated from mRNA-tagging
samples were normalized in a manner that was inherently required
for this system. The mock signal values were generated from an anti-
PABP immunoprecipitation which isolates all PABP-bound messages
in the entire cell culture or tissue analyzed. However, the infected
sample values were derived using an anti-FLAG immunoprecipitation
to specifically isolate the infected-cell minority subset of the
population. Therefore, an mRNP-tagging normalization step was
utilized to account for two parameters: 1) The disparity in the cell
population size of the mock and infected samples assayed by the
mRNP-tagging system, and 2) any difference in the immunoprecipi-
tating antibody strength (the polyclonal anti-PABP antibody versus
the monoclonal anti-FLAG antibody). To do so, raw GAPDH CT values
were generated from mRNP-tagging samples in the following
manner. From FLAG-PABP VRP infected samples, raw GAPDH CT
values were generated from both anti-FLAG and anti-PABP
immunoprecipitation-derived cDNA, representing GAPDH expres-
sion in the infected cell subset or the entire culture, respectively.
However from mock samples, raw GAPDH CT values were solely
generated from anti-PABP immunoprecipitation-derived cDNA, thus
representing the expression of GAPDH in the entire cell population.
Therefore, to normalize the mock control values for comparison to
the infected samples, a ratio of the anti-FLAG GAPDH signal to the
anti-PABP GAPDH signal was applied to account for the difference in
cell population size and antibody strength (r):
iÞ VRP anti FLAG rawGAPDH CT value
VRP anti PABP rawGAPDH CT value
¼ 00r00
This ratio was then applied to the mock anti-PABP raw GAPDH CT
value to generate a normalized mock GAPDH value:
iiÞ ðrÞ3ðmock anti PABP rawGAPDH CT valueÞ
¼ Normalized mockGAPDH CT
This normalized CT value served as the input mock GAPDH value
for the standard DCT analysis, as described above for total RNA.
Supporting Information
Figure S1. FLAG-PABP Does Not Reassort with Endogenous PABP
To address the degree, if any, of PABP reassortment in our system,
L929 cells were pretreated with AMD (4 ug/ml) for 1 h prior to
infection with FLAG-PABP VRP. AMD inhibits DNA-dependent RNA
transcription, thereby preventing the synthesis of new host RNA
during infection, but does not inhibit viral RNA-dependent RNA
synthesis. AMD-pretreated cells were subsequently infected with
FLAG-PABP VRP, and anti-FLAG immunoprecipitation was used to
isolate host mRNA from either PBS or AMD-pretreated infected cells
at 2 and 5 h following FLAG-PABP VRP infection. The expression
level of various host messages were analyzed by RPA, and the raw
pixel values quantified for IRF-1 mRNA expression is presented
above as representative data. Under AMD treatment, a complete
absence of host mRNA in anti-FLAG immunoprecipitated lysates was
observed in comparison to PBS-pretreated cells. Therefore, the VRP-
supplied tagged-PABP did not reassort with endogenous PABP for
binding to host mRNA.
Found at doi:10.1371/journal.ppat.0030199.sg001 (13 KB PDF).
Figure S2. mRNP-Tagging Sensitivity: IRF-1 Quantitation (Figure 4)
Table S1 and Figure S2 represent quantitation of the IRF-1 signal
from the RPA gel depicted in Figure 4. The raw pixel values are listed,
as well as plotted against the corresponding percentage of the lysate
assayed that was from infected cells, to allow further assessment of
the level of sensitivity in the mRNP-tagging system. Experimental
details: At 6 hpi, cell lysates (1 ml) were prepared from 106 L929 cells
that had been infected with FLAG-PABP VRP (MOI¼5). The resulting
lysates were mixed in decreasing ratios of infected lysate to mock
lysate, to a total volume of 200 ll. Anti-FLAG immunoprecipitation
was performed to isolate RNA from the infected cell portion of this
mixed lysate. To assess the mRNA signal recovered from the infected
cells, an RPA was used to detect the expression levels of host mRNA.
Signal from infected cell RNA within the mixed lysate was detected in
samples comprised of as little as 1% infected cell lysate, a value
approximately equal to 2 3 103 infected cells. Band signal
quantitation was completed using ImageQuant software (GE Health-
care).
Found at doi:10.1371/journal.ppat.0030199.sg002 (6 KB PDF).
Figure S3. Comparative VRP Infectivity Data for BHK, L929, and
BMDC at High and Low MOI
To compare the level of permissiveness of different cell types for
infection by VRP, flow cytometry analysis was completed using GFP-
VRP at high and low MOI. 105 BHK, L929, or BMDC were either mock
infected or infected with GFP-VRP, and harvested at 12 hpi. The cells
were washed once with cold PBS, and fixed with PBS/1% parafor-
maldehyde before FACS analysis. FACS data were acquired using a
Dako CyAn Flow Cytometer, with GFP serving as the marker for
infected cells. The data were analyzed using Summit software (Dako),
and are represented as the geometric mean (n¼3) 6 the standard
error of the mean. (A) BHK and L929 infectivity data. (B) Relative
infectivity of wildtype versus IFNabR/ primary BMDC. (C) Relative
mean fluorescence intensity of GFP expressed from the 26S promoter
of wildtype versus IFNabR/ primary BMDC.
Found at doi:10.1371/journal.ppat.0030199.sg003 (12 KB PDF).
Table S1. IRF-1 Signal Quantitation (Figure 4)
Found at doi:10.1371/journal.ppat.0030199.st001 (13 KB XLS).
Accession Numbers
The NCBI GenBank (http://www.ncbi.nlm.nih.gov/Genbank/index.
html) accession and GeneID numbers for genes mentioned in the
text are GAPDH (NM_008084.2, GeneID 14433); IFNb
(NM_010510.1, GeneID 15977); IL-6 (NM_031168.1, GeneID
16193); IP-10 (NM_021274.1, GeneID 15945); IRF-1 (NM_008390.1,
GeneID 16362).
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